Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma

Guardado en:

Bibliografiske detaljer
Udgivet i:	Journal for Immunotherapy of Cancer vol. 13, no. 2 (Feb 2025), p. e009352
Hovedforfatter:	Eigentler, Thomas
Andre forfattere:	Thomas, Ioannis, Samoylenko, Igor, Erdmann, Michael, Heinzerling, Lucie, Ochsenreither, Sebastian, Krauss, Jürgen, Oberoi, Arjun, Robert, Caroline, Lebbe, Celeste, Martin-Liberal, Juan, Koch, Lukas, Richtig, Erika, Terheyden, Patrick, Weishaupt, Carsten, Mohr, Peter, Semiletova, Yulia, Casilda Llacer Perez, Brossart, Peter, Bauernfeind, Franz Georg, Fluck, Michael, Poltoratskiy, Artem, Sekacheva, Marina, Soria, Ainara, Schmitt-Bormann, Beate, Gonzalez, Marina, Heß, Jana, Wengenmayer, Peter, Seibel, Tobias, Koch, Sven D, Quintini, Gianluca, Codó, Paula, Falk, Martin, Schönborn-Kellenberger, Oliver, Gnad-Vogt, Ulrike
Udgivet:	BMJ Publishing Group LTD
Fag:	Head & neck cancer Biomarkers Squamous cell carcinoma Vaccines Cell death Metastasis Melanoma Peptides Tumors Cancer therapies Immunology Proteins Skin cancer
Online adgang:	Citation/Abstract Full Text + Graphics Full Text - PDF
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Vær først til at give en kommentarø!